1. Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, et al. Granulomatosis with polyangitis (Wegener’s): an alternative name for Wegener’s Granulomatosis. Ann Rheum Dis 2011; 70(4):704.
2. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener Granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116(6):488–98.
3. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 1992; 83(302):427–38.
4. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener’s Granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43(5):1021–1032.
5. Srouji IA, Andrews P, Edwards C, Lund VJ. Patterns of presentation and diagnosis of patients with Wegener’s Granulomatosis: ENT aspects. J Laryng Olotol 2007; 121(7):653–8.
6. Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98(2):97–111.
7. Lund V, Cambridge G. Immunological aspects of Wegener's Granulomatosis. In: Passali D, Veldman JE, Lim DJ, editors. New frontiers in immunobiology. The Netherlands: Kugler Publications; 2000. p. 195–207.
8. Ahmad I, Lee WC, Nagendran V, Wilson F, Shortridge RT. Localized Wegener’s Granulomatosis in otolaryngology: a review of six cases.
ORL J Otorhinolaryngol Relat Spec. 2000; 62(3):149–55.
9. Bakheit AM, Behan PO. Localized Wegener’s Granulomatosis- a difficult and delayed diagnosis. Clinical report and literature review. Ir J Med Sci 1990; 159(2):55–7.
10. Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M. Wegener’s Granulomatosis in Finland in 1981–2000: clinical presentation and diagnostic delay. Scand J Rheumatol 2008; 37(6): 435–8.
11. Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, et al. Improved outcome of 445 Wegener’s Granulomatosis patients in a German vasculitis center over four decades. Arthritis Rheum. 2011; 63(1):257–66.
12. Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, et al. ANCA are detectable in nearly all patients with active severe Wegener’s Granulomatosis. Am J Med 2007; 120(7): 643.e9–14.
13. De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthr Rheum 2005; 52(8):2461–9.
15. Rasmussen N, Petersen J, Jensen H, Andersen V. Histopathological findings in biopsies from patients with Wegener’s Granulomatosis. APMIS 1990; Suppl 19:15–16.
16. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitis’s and polyarteritisnodosa for epidemiological studies. Ann Rheum Dis 2007; 66(2):222–7.